These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17305652

  • 21. The intake of flavonoids and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    Mursu J, Nurmi T, Tuomainen TP, Ruusunen A, Salonen JT, Voutilainen S.
    Br J Nutr; 2007 Oct; 98(4):814-8. PubMed ID: 17466095
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance.
    Nilsson PM, Hedblad B, Donaldson J, Berglund G.
    Blood Press; 2007 Oct; 16(2):95-100. PubMed ID: 17612907
    [Abstract] [Full Text] [Related]

  • 24. The effects of rosiglitazone on atherosclerotic progression in patients with Type 2 diabetes at high cardiovascular risk.
    Yee MS, Pavitt DV, Dhanjil S, Godsland IF, Richmond W, Johnston DG.
    Diabet Med; 2010 Dec; 27(12):1392-400. PubMed ID: 21059092
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y, Liu H, Liu F, Ouyang L, Cheng M, Gao L, Pan F, Liu Y, Chen X, Li J.
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Kidney function and progression of carotid intima-media thickness in a community study.
    Desbien AM, Chonchol M, Gnahn H, Sander D.
    Am J Kidney Dis; 2008 Apr; 51(4):584-93. PubMed ID: 18371534
    [Abstract] [Full Text] [Related]

  • 29. Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus.
    Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Liapis CD, Alevizos M.
    Diabet Med; 2008 Mar; 25(3):333-40. PubMed ID: 18307460
    [Abstract] [Full Text] [Related]

  • 30. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD.
    Zoungas S, Cameron JD, Kerr PG, Wolfe R, Muske C, McNeil JJ, McGrath BP.
    Am J Kidney Dis; 2007 Oct; 50(4):622-30. PubMed ID: 17900462
    [Abstract] [Full Text] [Related]

  • 31. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.
    Krentz A.
    Diabetes Metab Res Rev; 2009 Feb; 25(2):112-26. PubMed ID: 19219860
    [Abstract] [Full Text] [Related]

  • 32. Association of waist and hip circumference with 12-year progression of carotid intima-media thickness in elderly women.
    Hassinen M, Lakka TA, Komulainen P, Haapala I, Nissinen A, Rauramaa R.
    Int J Obes (Lond); 2007 Sep; 31(9):1406-11. PubMed ID: 17372615
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
    van Doorn M, Vogels J, Tas A, van Hoogdalem EJ, Burggraaf J, Cohen A, van der Greef J.
    Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
    [Abstract] [Full Text] [Related]

  • 34. Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.
    Forst T, Hohberg C, Fuellert SD, Lübben G, Konrad T, Löbig M, Weber MM, Sachara C, Gottschall V, Pfützner A.
    Horm Metab Res; 2005 Aug; 37(8):521-7. PubMed ID: 16138267
    [Abstract] [Full Text] [Related]

  • 35. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.
    Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B.
    Circulation; 2004 Mar 02; 109(8):1010-5. PubMed ID: 14769704
    [Abstract] [Full Text] [Related]

  • 36. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.
    Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, Osonoi T, Kaneto H, Kosugi K, Umayahara Y, Yamamoto T, Matsumoto K, Yokoyama H, Tsugawa M, Gosho M, Shimomura I, Watada H, Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial.
    Diabetes Care; 2016 Mar 02; 39(3):455-64. PubMed ID: 26822324
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study.
    Alssema M, Dekker JM, Kuivenhoven JA, Nijpels G, Teerlink T, Scheffer PG, Diamant M, Stehouwer CD, Bouter LM, Heine RJ.
    Diabet Med; 2007 Feb 02; 24(2):117-23. PubMed ID: 17257272
    [Abstract] [Full Text] [Related]

  • 40. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
    Lonn EM, Gerstein HC, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais GR, DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) and STARR Investigators.
    J Am Coll Cardiol; 2009 Jun 02; 53(22):2028-35. PubMed ID: 19477351
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.